1. University of Rochester v. G.D. Searle & Co., Inc., 358 F.3d 916 (Fed. Cir.), reh'g en banc denied, 375 F.3d 1303, cert. denied, 160 L. Ed. 2d 484 (2004).
2. The Trilateral Co-operation. Mutual understanding in search and examination: comparative study on biotechnology patent practices (Trilateral Project B3b) (The Trilateral Co-operation, 2001).
http://www.trilateral.net/projects/biotechnology/reach_through_claims/
3. Avorn, J. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs (Knopf, New York, 2004).
4. Marcia Angell. The Truth About the Drug Companies: How They Deceive Us and What To Do About It (Random House, New York, 2004).
5. American Hospital Formulary Service. Antilipemic agents 24:06, HMG-CoA reductase inhibitors (American Society of Health-System Pharmacists, Bethesda, MD, USA, 2002).